TEAD3
TEAD3 (TEA domain transcription factor 3, also known as TEF-5, ETFR-1 and TEAD5) is a nuclear transcription factor of the TEA domain family. It acts in the Hippo signalling pathway, where it mediates gene expression driven by YAP1 and WWTR1/TAZ. Browse Assay Genie's current range of TEAD3 research reagents below, or read on for the biology behind the target.
TEAD3 is a transcription factor that plays a key role in the Hippo signalling pathway, which controls organ size and suppresses tumours by restricting proliferation and promoting apoptosis. The core of the pathway is a kinase cascade. MST1/MST2, in complex with the regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with MOB1. LATS1/2 in turn phosphorylates and inactivates the YAP1 oncoprotein and WWTR1/TAZ. TEAD3 acts by mediating the gene expression of YAP1 and WWTR1/TAZ, and so helps regulate cell proliferation, migration and the induction of epithelial mesenchymal transition (EMT).
The TEAD3 protein belongs to the transcriptional enhancer factor (TEF) family, whose members contain the TEA/ATTS DNA-binding domain. It is localised to the nucleus and is predominantly expressed in the placenta. There it contributes to transactivation of the chorionic somatomammotropin-B gene enhancer, and it binds to multiple functional elements of that enhancer. Translation of the protein starts at a non-AUG (AUA) start codon, which is an unusual feature of this gene.
The TEAD3 gene is listed by HGNC in the TEA domain transcription factors group. Its previous name was TEA domain family member 3, and the protein is also called transcriptional enhancer factor TEF-5. The aliases ETFR-1 and TEAD5 appear in the literature. The mouse ortholog is Tead3. Other family members, such as TEAD1 and TEAD4, are useful for comparative work on Hippo pathway transcriptional output.
TEAD3 is a transcriptional effector of the Hippo pathway, which restricts proliferation and promotes apoptosis to control organ size.
TEAD3 mediates gene expression driven by YAP1 and WWTR1/TAZ, making it central to studies of how pathway output is read out.
TEAD3 helps regulate cell proliferation, migration and induction of epithelial mesenchymal transition, processes relevant to tumour biology.
TEAD3 is predominantly expressed in the placenta and is involved in transactivating the chorionic somatomammotropin-B gene enhancer.
TEAD3 is a transcription factor in the Hippo signalling pathway. It mediates gene expression of YAP1 and WWTR1/TAZ, thereby regulating cell proliferation, migration and EMT induction. It also binds functional elements of the chorionic somatomammotropin-B gene enhancer and is predominantly expressed in the placenta.
TEAD3 is also called TEF-5, ETFR-1 and TEAD5, and its UniProt name is transcriptional enhancer factor TEF-5. HGNC previously named it TEA domain family member 3. It belongs to the TEA domain transcription factors, which share the TEA/ATTS DNA-binding domain.
A mouse ortholog, Tead3, is recorded for this gene. The TEAD3 gene is one member of a TEA domain family that includes TEAD1 and TEAD4. Check the datasheet of any product for its validated reactivity before using it in a given species.
Other TEA domain transcription factors that act as Hippo pathway effectors.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q99594; product specifications from Assay Genie datasheets.